摘要
本文介绍46例恶性肿瘤患者实施冻存胎儿胸腺移植前后的 E 玫瑰花形成细胞(E-RFC)水平的变化。移植后较移植前 E-RFC 水平升高(p<0.05)。根据移植前 E-RFC 水平,我们将46例患者分为3组:第1组,E-RFC 水平在40%以下者(7例);第2组,E-RFC 水平在41%~60%之间者(24例),第3组,E-RFC 水平在61%以上者(15例)。移植后各组 E-RFC 水平较移植前平均升高值分别为:22.2%(p<0.01)、7%(p<0.01)、-5.1%(0.2>p>0.1)。从结果看出,通过冻存胎儿胸腺移植可以提高恶性肿瘤患者的E-RFC 水平,特别是 E-RFC 水平在60%以下者。E-RFC 水平在61%以上者实施冻存胎儿胸腺移植无提高 E-RFC 水平作用。
The E-RFC levels of 46 cases of malignant tumor were measured before and after the transplantation of cryopreserved fetal thymus.Based on the E-RFC values before transplan- tation 46 cases were divided into three groups:(1)E-RFC values below 40% (7 cases); (2)E-RFG values between 41%-60% (24 cases) and (3)E-RFC values over 61% (15 cases).After transplantation,the average E-RFC values of the three groups were higher than before by +22.2%(p<0.01),+7.0%(p<0.01) and -5.1% (0.2>p>0.1) respectively. The results suggest that the immunological function of malignant tumor patients with E-RFC values below 60% can be improved by transplantation of cryopreserved fetal thymus.
出处
《军事医学科学院院刊》
CSCD
北大核心
1991年第4期290-294,共5页
Bulletin of the Academy of Military Medical Sciences
关键词
恶性肿瘤
冻存胎儿胸腺移植
治疗
免疫功能
cryopreserved fetal thymus
transplantation
immunological function
E-RFC values